Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure

Medical Science Monitor

Volumn 9, Issue 1, 2003, Pages

  Kotikoski, Hanna ^a   Kankuri, Esko ^a   Vapaatalon, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cyclic GMP; Intraocular pressure; Iris ciliary body; Nitric oxide; NO donors

Indexed keywords

4 ETHYL 2 [HYDROXYIMINO (5 NITRO 2 HEXENAMIDE)]; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; CYCLIC GMP; GUANYLATE CYCLASE; N [4 [1 (3 AMINOPROPYL) 2 HYDROXY 2 NITROSOHYDRAZINO[BUTYL (1,3 PROPANEDIAMINE)]]]; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; NITROSOCAPTOPRIL; S NITROSOTHIOL; SPERMINE; UNCLASSIFIED DRUG; ZAPRINAST;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CILIARY BODY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GLAUCOMA; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE ABNORMALITY; IRIS; NONHUMAN; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY; SWINE;

ANIMALS; CAPTOPRIL; CILIARY BODY; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUANYLATE CYCLASE; INTRAOCULAR PRESSURE; IRIS; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRITES; NITRO COMPOUNDS; NITROGEN OXIDES; OXADIAZOLES; PENICILLAMINE; PHOSPHODIESTERASE INHIBITORS; PURINONES; QUINOXALINES; RABBITS; S-NITROSOTHIOLS; SPERMINE; SWINE; TIME FACTORS;

EID: 0037276903     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Moncada S, Palmer RMJ, Higgs EA: Biosynthesis of nitric oxide from l-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol, 1989; 38: 1709-1715
2. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med, 1993; 30: 2002-2012
3. Ignarro LJ, Cirino G, Casini A, Napoli C: Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol, 1999; 34: 879-886
4. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J, 2001; 357: 593-615
5. Ignarro LJ: Nitric oxide - a novel signal transduction mechanism for transcellular communication. Hypertension, 1990; 16: 477-483
6. Wiederholt M, Sturm A, Lepple-Wienhues A: Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci, 1994; 35: 2515-2520
7. Nathanson JA: Atriopeptin-activated guanylate cylase in the anterior segment: identification, localization, and the effects of atriopeptins on IOP. Invest Ophthalmol Vis Sci, 1987; 28: 1357-1364
8. Korenfeld MS, Becker B: Atrial natriuretic peptides: effects on intraocular pressure, cGMP, and aqueous flow. Invest Ophthalmol Vis Sci, 1989: 30: 2385-2392
9. Millar JC, Shahidullah M, Wilson WS: Atriopeptin lowers aqueous humor formation and intraocular pressure and elevates ciliary cyclic GMP but lacks uveal vascular effects in the bovine perfused eye. J Ocul PharmacoI Ther, 1997; 13: 1-11
10. Geyer O, Podos SM, Mitag T: Nitric oxide activity in tissues of the bovine eye. Graefe's Arch Clin Exp Ophthalmol, 1997; 235: 786-793
11. Nathanson JA, McKee M: Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci, 1995; 36: 1765-1773
12. Haufschild T, Tschudi MR, Flammer J et al: Nitric oxide production by isolated human and porcine ciliary processes. Graefe's Arch Clin Exp Ophthalmol, 2000; 238: 448-453
13. Osborne NN, Barnett NL, Herrera AJ: NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res, 1993; 610: 194-198
14. Meyer P, Champion C, Schlötzer-Schrehard U et al: Localization of nitric oxide synthase isoforms in porcine ocular tissues. Curr Eye Res, 1999; 18: 375-380
15. Nathanson JA, McKee M: Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci, 1995; 36: 1774-1784
16. Kotikoski H, Alajuuma P, Moilanen E et al: Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther, 2002; 18: 11-23
17. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem, 1951; 193: 265-275
18. Adams MWW, Mortenson LE: The effect of cyanide and ferricyanide on the activity of the dissimilatory nitrate reductase of Escherichia coli. J Biol Chem, 1982; 257: 1791-1799
19. Feelisch M, Stamler JS: Donors of nitrogen oxides. In: Feelisch M, Stamler JS, editors. Methods in Nitric Oxide Research. Chichester: John Wiley & Sons, 1996; 71-118.
20. Becquet F, Courtois Y, Goureau O: Nitric oxide in the eye: multi-faceted roles and diverse outcomes. Surv Ophthalmol, 1997; 42: 71-82
21. Nathanson JA: Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther, 1992; 260: 956-965
22. Schuman J, Erickson K, Nathanson JA: Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res, 1994; 58: 99-105
23. Behar-Cohen FF, Goureau O, D'Hermies F, Courtois Y: Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci, 1996; 37: 1711-1715
24. Becker B: Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits. Invest Ophthalmol Vis Sci, 1990; 31: 1647-1649
25. Samuelsson-Almen M, Nilsson SFE, Mäepea O, Bill A: Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey. Exp Eye Res, 1991; 53: 253-260
26. Stein PJ, Clack JW: Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits. Invest Ophthalmol Vis Sci, 1994; 35: 2765-2768
27. Takashima Y, Taniguchi T, Yoshida M et al: Ocular hypotensive mechanism ofintravitreally injected brain natriuretic peptide in rabbit. Invest Ophthalmol Vis Sci, 1996; 37: 2671-2677
28. Friebe A, Schulz G, Koesling D: Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J, 1996; 15: 6863-6868
29. Galle J, Zabel U, Hubner U et al: Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP and phosphodiesterase activity. Br J Pharmacol, 1999; 127: 195-203
30. Gob Y, Hotehama Y, Mishima HK: Characterization of ciliary muscle relaxation induced by various agents in cats. Invest Ophthalmol Vis Sci, 1995; 36: 1188-1192
31. Azuma H, Masuda H, Sato J et al: A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle. Exp Eye Res, 1997; 64: 823-830
32. Ding K-H, Abdel-Latif AA: Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles. Invest Ophthalmol Vis Sci, 1997; 38: 2629-2638
33. Masuda H, Tamaoki S, Goto M et al: Nitric oxide-induced ciliary muscle relaxation during contraction with endothelin-1 is mediated through elevation of cyclic GMP. Curr Eye Res, 1997; 16: 1245-1251
34. Fujimoto N, Hanawa T, Kimura T: Effect of c-AMP- and cGMP-related drugs on porcine cultured ciliary muscle. J Ocul Pharmacol Ther, 1998; 14: 247-252
35. Kamikawatoko S, Tokoro T, Ishida A et al: Nitric oxide relaxes bovine ciliary muscle contracted by carbachol through elevation of cyclic GMP. Exp Eye Res, 1998; 66: 1-7
36. Shahidullah M, Wilson WS: Atriopeptin, sodium azide and cyclic GMP reduce secretion of aqueous humor and inhibit intracellular calcium release in bovine cultured ciliary epithelium. Br J Pharmacol, 1999; 127: 1438-1446